Mateusz Ługowik

Mateusz Ługowik is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Gdańsk, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Millennium Group Shares Flat at $1.41 Pre-market—Small-Cap Packaging Risks Still Lurk
·

Millennium Group Shares Flat at $1.41 Pre-market—Small-Cap Packaging Risks Still Lurk

Millennium Group International Holdings Ltd shares in the U.S. were last seen at $1.41 ahead of the Nasdaq open Thursday, slipping 0.71% from the prior close. The Hong Kong paper-packaging supplier’s market cap sat at roughly $15.9 million. Regular session trading was still to start. MGIH trades light, with limited volume making the price jump on smaller orders. Google Finance puts its 52-week range between $1.11 and $4.84, and average daily turnover at just 9,230 shares. That low volume often leads to shaky premarket moves that might not hold.
June 4, 2026
Roper Technologies Stock Slips Again: Why the $3 Billion Buyback Is Now in Focus
·

Roper Technologies Stock Slips Again: Why the $3 Billion Buyback Is Now in Focus

Roper Technologies shares enter Thursday under pressure after closing at $331.70, down 1.4% from the previous close, with the regular Nasdaq session still ahead. The stock’s latest quoted market value was about $34.7 billion. The timing matters. Nasdaq’s regular trading day runs from 9:30 a.m. to 4:00 p.m. Eastern time, and June 4 is not one of the exchange holidays listed for 2026. That puts Roper’s next move in live trading, not in a weekend or holiday tape.
June 4, 2026
MetaVia Stock Slips Again Before a Big Obesity-Drug Week
·

MetaVia Stock Slips Again Before a Big Obesity-Drug Week

MetaVia Inc. shares slipped before the bell on Thursday, extending a sharp pullback from last week’s rally as investors weighed early obesity-drug data against financing and listing risks at the small biotech. The Nasdaq-listed stock was quoted at $2.65 in pre-market trade, down 1.1%, after a $2.68 close on Wednesday. It has now retreated from $3.34 on May 27, the day MetaVia presented new Phase 1 data for DA-1726 at the European Association for the Study of the Liver Congress.
June 4, 2026
MYR Group Drops in Pre-Market Ahead of Investor Calls, Insider Selling
·

MYR Group Drops in Pre-Market Ahead of Investor Calls, Insider Selling

MYR Group Inc. shares slipped in early Nasdaq premarket trade Thursday. The move puts the electrical contractor’s strong 2026 run back in focus as company executives meet institutional investors in New York. Recent insider filings are also drawing attention. The stock last changed hands at $441.35, off $9.62, or roughly 2.1% lower than Tuesday’s close. That trade came in at 4:31 a.m. EDT, ahead of the U.S. market open.
June 4, 2026
CXApp Stock on the Move Pre-Market After EngineRoom AI Announcement
·

CXApp Stock on the Move Pre-Market After EngineRoom AI Announcement

CXApp Inc. shares were up in early premarket trading Thursday after the workplace AI software maker said it bought Australia’s EngineRoom. Management said the deal would more than triple its annualized revenue run-rate. Webull showed CXAI at 25.94 cents as of 4:11 a.m. EDT, a jump of 62.9% from the prior close at 15.92 cents. Benzinga reported CXAI touched 28 cents after hours on the news. CXApp is thinly traded and its Nasdaq stock is still under the $1 minimum bid. Any deal that brings in revenue helps. Timing also counts. Shareholders will vote June 16 on a reverse split to reduce share count and push the price up, aimed at keeping the listing.
June 4, 2026
Prelude Therapeutics Rises Pre-Market With Focus on Two Cancer Drugs
·

Prelude Therapeutics Rises Pre-Market With Focus on Two Cancer Drugs

Prelude Therapeutics shares traded higher in premarket action Thursday, after the cancer-drug maker showed up at an investor event in New York on Wednesday. The move brought the stock back into focus for traders. Prelude last traded at $3.66 for a market cap near $302 million. The SPDR S&P Biotech ETF was up 1.6% in its latest trade. The iShares Nasdaq Biotechnology ETF gained 2.0%.
June 4, 2026
bioAffinity Technologies Stock Draws Fresh Attention From Traders
··

bioAffinity Technologies Stock Draws Fresh Attention From Traders

bioAffinity Technologies Inc. traded at $1.69 in the latest quote, up five cents from its last close. The stock caught a small bump after the diagnostics firm filed a new notice on physician education related to its CyPath Lung cancer test. With a market cap near $7.6 million, any buying or selling tends to swing the share price. Society for Advanced Bronchoscopy is planning a June 16 webinar to talk about CyPath Lung and its use in pulmonary, oncology, and surgical work for early lung cancer detection and management, according to a June 2 filing. Shares and warrants of the company are listed on Nasdaq Capital Market under the symbols BIAF and BIAFW.
June 4, 2026
Arq Drops 4.6% Ahead of Next Major GAC Test
·

Arq Drops 4.6% Ahead of Next Major GAC Test

Arq, Inc. shares dropped 4.6% to $2.60 late Wednesday in U.S. trading. Around 240,000 shares traded. That’s a steeper decline than the iShares Russell 2000 ETF, which fell 1.4%. $2.60 marked the session low for Arq. Arq shares slipped as the market stayed soft, but investors’ concerns are clear: they want more details on Arq’s granular activated carbon, or GAC, business. GAC is used in filtration to strip out contaminants. Arq said it’s still working on the process design, figuring out capital needs, and looking at timing. The company is aiming to have a new plan in place for the third quarter of 2026.
June 3, 2026
Expion360 Stock Drops as Nasdaq Timeline Pressures XPON
·

Expion360 Stock Drops as Nasdaq Timeline Pressures XPON

Expion360 Inc. dropped 6.6% to $0.5036 late Wednesday after a new underperform rating landed on the stock and weak Q1 numbers dragged it closer to its 52-week low. Investors also have a Nasdaq listing deadline in play. Shares last changed hands at 15:32 EDT, with the company's market cap at about $5.3 million. XPON is still trading under Nasdaq’s $1 minimum bid rule, so the move is significant for the stock. The exchange requires shares to stay above that price or risk delisting. Expion360 said in its quarterly filing that Nasdaq has given it until July 28, 2026, to fix the price. A reverse split, which would cut share count and push up the stock price, is still on the
June 3, 2026
Lite Strategy Stock Faces Litecoin Setback
·

Lite Strategy Stock Faces Litecoin Setback

Lite Strategy Inc shares were higher in midday trading Wednesday in the U.S., while Litecoin edged lower. The small crypto-treasury's valuation on Nasdaq is drawing attention as traders work to close the gap. The stock traded as high as $0.87 and as low as $0.80, last changing hands at $0.83 for a 1.7% gain. Volume was around 349,000 shares. Litecoin, Lite Strategy’s core reserve asset, fell 1.5% to $47.47.
June 3, 2026
Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming
·

Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming

Kyverna Therapeutics shares were little changed on Wednesday after the company released updated early-stage rheumatoid arthritis data for miv-cel, its lead autoimmune cell therapy, leaving investors to weigh a broader pipeline story against the usual limits of a tiny trial. The timing matters because Kyverna is trying to show that miv-cel can be more than a single-disease bet. CAR T, or chimeric antigen receptor T-cell therapy, re-engineers immune cells to attack a target; miv-cel is an autologous therapy, meaning it is made from a patient’s own cells, and targets CD19, a marker found on B cells involved in several autoimmune diseases.
June 3, 2026
Telesat Shares Drop Ahead of AGM With Lightspeed Concerns Returning
·

Telesat Shares Drop Ahead of AGM With Lightspeed Concerns Returning

Telesat Corp shares dropped 5.1% to $47.57 early Wednesday on Nasdaq, as trading stayed volatile before the Canadian satellite company’s annual shareholder meeting scheduled for later. Shares began the day at $49.39 and sank to an intraday low of $47.18, according to the latest data. Telesat shareholders meet online at 1:30 p.m. Ottawa time, where they’ll vote on typical annual items like the audited financials, board members and Deloitte’s auditor role. But investors are watching for signs on how fast the company can get its Lightspeed satellite project moving and start showing growth.
June 3, 2026
J-Star Moves Up in Premarket on $122.5 Million Texas Battery Deal Behind YMAT
·

J-Star Moves Up in Premarket on $122.5 Million Texas Battery Deal Behind YMAT

J-Star Holding Co., Ltd. stock gained in U.S. premarket trading Wednesday, as the Taiwan composites firm outlined more details for its planned $122.5 million solid-state battery facility in Baytown, Texas. Public.com had YMAT at $1.34 at 7:00 a.m. ET, 47.25% above Tuesday’s close at $0.91. Premarket trading generally sees lighter volumes ahead of the Nasdaq session. Solid-state batteries rely on solid electrolyte instead of a liquid or gel to transfer charge in each cell. Market focus was less on current earnings and more on specific project milestones. J-Star said Tuesday it now has support for its plan thanks to a Taiwan Central Bank authorization for a planned $60 million outbound investment, along with a formal site commitment from the Baytown
June 3, 2026
PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB
·

PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB

PDS Biotechnology Corporation shares traded higher after the cancer immunotherapy company said Nasdaq signed off on its compliance with the $1 minimum bid-price rule. That wraps up a deficiency issue that’s been on the stock since February. The minimum bid requirement says a listed stock has to stay over a certain price to keep its exchange listing. Nasdaq’s June 2 notice takes off the immediate delisting risk for PDSB, which had traded under $1 for 30 business days in a row earlier this year, according to a filing. The company still faces the same clinical and cash needs as before, but now without the near-term threat of a delisting process tied to that breach.
June 3, 2026
LegalZoom Drops Ahead of Shareholder Meeting as AI Fight Hangs Over Stock
····

LegalZoom Drops Ahead of Shareholder Meeting as AI Fight Hangs Over Stock

LegalZoom.com traded lower in premarket Wednesday, with the stock near $6.53 as investors prepared for the company’s annual meeting. Shares have had trouble translating stronger sales into better numbers on the bottom line. The latest price was off 14.5 cents from Tuesday’s close, giving LegalZoom a market cap near $1.16 billion. The timing sets the scene. U.S. markets are open as usual, and Nasdaq’s 2026 holiday list shows the next full day off is Juneteenth, June 19. LegalZoom’s shareholder meeting is scheduled for later in the day, not on a weekend or holiday.
June 3, 2026
ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention
····

ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention

ChampionsGate Acquisition Corporation stock was flat in premarket trading Wednesday. The Nasdaq-listed SPAC stayed near the level investors could redeem for cash if the company doesn’t seal a merger. The stock last changed hands at $10.35, off 0.07% in the past 24 hours. TradingView data showed the market shut with no fresh trades on the tape at the time. It had a market cap near $103.4 million.
June 3, 2026
Littelfuse Shares Rise as AI Data-Center Story Hits
····

Littelfuse Shares Rise as AI Data-Center Story Hits

Littelfuse Inc. shares jumped Tuesday, closing at a new 52-week high as the AI data-center product debut landed. The stock, which trades on the Nasdaq, finished at around $487.90, up 5.3%. It hit $489.60 during the day. Investors have pushed the shares higher since its first-quarter earnings. Littelfuse is making its pitch now as it wants to prove its circuit-protection products belong in new higher-power data center projects, not just in industrial or automotive use. Regular U.S. trading opens later Wednesday; Nasdaq’s standard hours run 9:30 a.m. to 4 p.m. ET, with pre-market trading from 4 a.m. ET.
June 3, 2026
Broadwind Shares Climb 8% as Traders Return to Small Manufacturer
····

Broadwind Shares Climb 8% as Traders Return to Small Manufacturer

Broadwind Inc. shares gained 8.1% Tuesday to finish at $4.02 on Nasdaq, with the Illinois-based manufacturer picking up trading interest following its big shift away from wind tower production. After hours, the stock slipped to $3.98. Broadwind is trading more as a niche precision manufacturer than a pure wind-market player now. The company’s market value stood at around $94 million, putting it in micro-cap territory. About 442,000 shares changed hands in recent trade, the data show.
June 3, 2026
Sify Shares Stuck, India AI Data-Center Bet Draws Traders
····

Sify Shares Stuck, India AI Data-Center Bet Draws Traders

Sify Technologies Limited’s American depositary receipts trading in the U.S. ended Tuesday mostly unchanged. The stock stalled after choppy moves, as investors considered the Indian digital infrastructure group's ongoing data-center expansion against bigger losses and rising debt. Sify ADRs were last at $17.24, up 0.12%, trading 82,064 shares, market data showed. An ADR, or American depositary receipt, is a certificate traded in the U.S. that stands for shares of a foreign company.
June 2, 2026
Marchex Shares Steady With Investors Watching AI Deal Vote
····

Marchex Shares Steady With Investors Watching AI Deal Vote

Marchex Inc. drifted down in late U.S. trading Tuesday. The shares closed at $1.64, off 1 cent from the last session. The thinly traded AI conversation-intelligence stock had volume of 11,961 shares, market data showed. Investors saw little new out of the company. The pending acquisition stayed in focus. That’s relevant now since Marchex hasn’t issued any fresh releases to its investor-news feed in the last 24 to 48 hours. The latest updates are still a May 13 first-quarter results release and a May 12 product announcement. So the immediate question stays on execution—if its Archenia deal and new AI products can drive revenue growth without piling on dilution or more integration risk.
June 2, 2026
1 … 22 23 24 25 26 … 39